Bleeding Disorders Treatment Market Projected To Reach USD 35.17 Billion By 2032, Growing At A Robust CAGR Of 8.91%
Driven by Biopharmaceutical Innovations and Gene Therapies, the market Booms Amidst Growing Incidence of Hemophilia and Von Willebrand Disease ...
Pharma giant partners with Durham firm to target sickle cell disease
IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...
Novo Nordisk Inks License Agreement For Sickle Cell Disease Candidate
IMMvention and Novo Nordisk form a partnership to co-develop oral therapies for sickle cell disease, focusing on BACH1 ...
kino16h
Nordisk Film Biografer Fields
Luksussæder til de store filmoplevelser i biografen med plads til hele familien Der er 4 timers gratis parkering, når du ser film i Field’s, hvis du parkerer i centrets p-kælder. Ved ankomst i ...
Bloomberg L.P.19h
Novo Nordisk A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...